CXCL1 and psoriasis: A recent study has shown that disruption of the epidermal barrier can exacerbate psoriasis by unregulated keratinocyte proliferation and the overexpression of S100A8, S100A9, CXCL1, and other molecules, indicating a defect in ceramide-dependent epidermal barrier signaling and function [73].